September 8, 2025

BridgeBio Pharma, Inc. (BBIO) Stock Analysis: Uncovering a 19.24% Upside with Robust Revenue Growth

BridgeBio Pharma, Inc. (NASDAQ: BBIO), a dynamic player in the biotechnology sector, is capturing investor attention with its remarkable revenue growth and significant potential upside. Known for its innovative approach..

Henry Schein, Inc. (HSIC) Stock Analysis: Navigating Growth in Healthcare Distribution with a 5.47% Upside Potential

Henry Schein, Inc. (NASDAQ: HSIC) stands as a formidable player in the healthcare sector, particularly in medical distribution. With a market capitalization of $8.42 billion, this Melville, New York-headquartered company..

Neurocrine Biosciences, Inc. (NBIX): Analyst Ratings Highlight 16.76% Potential Upside for Investors

Neurocrine Biosciences, Inc. (NBIX), headquartered in San Diego, California, is making waves in the healthcare sector, specifically within the specialty and generic drug manufacturing industry. With a market capitalization of..

Option Care Health, Inc. (OPCH) Stock Analysis: A Promising 33% Upside Potential in the Healthcare Sector

Option Care Health, Inc. (NASDAQ: OPCH) has carved a niche for itself in the healthcare sector by specializing in home and alternate site infusion services. Headquartered in Bannockburn, Illinois, OPCH..

Guardant Health, Inc. (GH) Stock Analysis: High Buy Ratings and Promising Revenue Growth in Precision Oncology

Guardant Health, Inc. (NASDAQ: GH) is garnering significant attention from investors as it continues to make strides in the healthcare sector, specifically within the diagnostics and research industry. Headquartered in..

ADMA Biologics Inc (ADMA) Stock Analysis: Navigating a 72% Potential Upside in the Biotech Sector

ADMA Biologics Inc (NASDAQ: ADMA), a key player in the biotechnology sector, is positioned at the forefront of developing and marketing specialty plasma-derived biologics. With a market capitalization of $4.03..

Bausch + Lomb Corporation (BLCO) Stock Analysis: Navigating Eye Health with a 5.10% Revenue Growth in the Competitive Healthcare Sector

Bausch + Lomb Corporation (NYSE: BLCO) stands as a significant player in the healthcare sector, specifically within the medical instruments and supplies industry. With its headquarters in Vaughan, Canada, Bausch..

Hologic, Inc. (HOLX) Stock Analysis: Navigating a 10.65% Upside Potential in the Healthcare Sector

Hologic, Inc. (NASDAQ: HOLX), a prominent player in the healthcare sector, stands out for its comprehensive portfolio in medical instruments and supplies. With a market capitalization of $14.85 billion, Hologic..

Waystar Holding Corp. (WAY) Stock Analysis: Exploring a 33.96% Potential Upside in Healthcare Tech

Waystar Holding Corp. (NASDAQ: WAY) is capturing the attention of investors with its robust position in the healthcare technology sector. Specializing in cloud-based software solutions for healthcare payments, Waystar is..

Krystal Biotech, Inc. (KRYS) Investor Outlook: Navigating the 36.55% Potential Upside

Krystal Biotech, Inc. (NASDAQ: KRYS) is capturing investor attention with its impressive potential upside of 36.55%, as indicated by current analyst ratings. This Pittsburgh-based biotechnology company, with a market capitalization..

Alkermes plc (ALKS) Stock Analysis: Navigating a 39% Potential Upside in Biopharma Innovation

Alkermes plc (NASDAQ: ALKS), a prominent player in the biopharmaceutical sector, offers investors a compelling opportunity with a potential upside of 39.1%. Headquartered in Dublin, Ireland, the company is renowned..

HealthEquity, Inc. (HQY) Stock Analysis: Exploring a Potential 33.75% Upside for Investors

HealthEquity, Inc. (HQY) stands out in the healthcare sector, specifically within the health information services industry. With a market capitalization of $7.88 billion, this Utah-based company has carved a niche..

The Cigna Group (CI) Investor Outlook: Exploring a Robust Upside Potential of 20.90%

Investors keen on healthcare stocks may find The Cigna Group (NYSE: CI) an intriguing prospect as it demonstrates a promising potential upside of 20.90%, according to current analyst ratings. With..

Revvity, Inc. (RVTY) Stock Analysis: Unveiling a 34.83% Upside Potential in Healthcare Diagnostics

Revvity, Inc. (NYSE: RVTY) stands as a prominent player in the healthcare sector, specifically within the diagnostics and research industry. With a market capitalization of $10.06 billion, this U.S.-based company..

Rhythm Pharmaceuticals, Inc. (RYTM) Investor Outlook: A Biotech with 10% Potential Upside and Promising Drug Pipeline

Rhythm Pharmaceuticals, Inc. (RYTM), a key player in the biotechnology sector, is making waves with its focus on rare neuroendocrine diseases. The company, headquartered in Boston, Massachusetts, has been capturing..

Novartis AG (NVS) Investor Outlook: Evaluating Growth Potential Despite Current Valuation Concerns

Novartis AG (NVS), a titan in the global healthcare sector, operates primarily in the drug manufacturing industry. Headquartered in Basel, Switzerland, the company is renowned for its extensive portfolio, including..

McKesson Corporation (MCK) Stock Analysis: A Healthcare Giant with a Promising 14.72% Upside

McKesson Corporation (NYSE: MCK), a stalwart in the healthcare sector, is a name synonymous with medical distribution in the United States and internationally. With a robust market capitalization of $85.5..

Integer Holdings Corporation (ITGR) Stock Analysis: Exploring a 31.73% Potential Upside

Integer Holdings Corporation (NYSE: ITGR), a prominent player in the healthcare sector, particularly in the medical devices industry, presents a compelling opportunity for investors seeking growth potential. With a market..

Chemed Corp (CHE) Stock Analysis: 25% Upside Potential Amidst Strong Performance Metrics

Chemed Corp (CHE), a key player in the healthcare sector, specifically in the medical care facilities industry, presents an intriguing investment opportunity with its current market dynamics suggesting a significant..

Doximity, Inc. (DOCS) Stock Analysis: Navigating Growth in Health Information Services

Doximity, Inc. (NYSE: DOCS) is making waves in the healthcare sector with its innovative digital platform tailored for medical professionals. As the company continues to gain traction, it presents a..

Search

Funds

September 8, 2025

Search

Funds

September 8, 2025

FTSE 100

Funds